Penicillin Allergy Label Increases Risk of Worse Clinical Outcomes in COVID-19

BACKGROUND: Coronavirus disease-2019 (COVID-19) ranges from asymptomatic to severe. Several comorbidities are associated with worse clinical outcomes. Antibiotic use is common in COVID-19 and penicillin (PCN) allergy can affect antibiotic choice and may influence COVID-19 outcomes. OBJECTIVE: To inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaminsky, Lauren W., Dalessio, Shannon, Al-Shaikhly, Taha, Al-Sadi, Rana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288230/
https://www.ncbi.nlm.nih.gov/pubmed/34293501
http://dx.doi.org/10.1016/j.jaip.2021.06.054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288230/
https://www.ncbi.nlm.nih.gov/pubmed/34293501
http://dx.doi.org/10.1016/j.jaip.2021.06.054

Ejemplares similares